BioCentury
ARTICLE | Company News

ADC Therapeutics, Genmab deal

April 13, 2015 7:00 AM UTC

Genmab did not exercise its co-development right for HuMax-TAC-ADC under a June 2013 deal to develop an antibody-drug conjugate (ADC) product to treat cancer. The option would have allowed Genmab to m...